Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Novo will pay $200 million to gain control of the protein manufacturing factory. Elsewhere, Roivant dropped a drug program ...

Shares of Vincerx Pharma saw volatile trading on Wednesday, swinging between gains and losses after the company unveiled ...

Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

Revolution has set itself a mission to revolutionize treatment for patients with RAS addicted cancers. See why I upgrade RVMD ...

Recent health news highlights include Novavax's $200 million sale of its Czech unit, UnitedHealth's higher medical cost ...

Mark Cuban (entrepreneur, investor, and founder, Cost Plus Drugs) joins Chris Cuomo to discuss disrupting Big Pharma, ...

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

If for no other reason than that it will elicit fear in the hearts of autocracy-phobics, I propose that Donald Trump’s second-term Cabinet be known as ...